Medtronic’s Prestige LP Joins LDR’s Mob-C In Two-Level Cervical Disc Competition

The US FDA approved Medtronic's artificial disc based on results of a 397-patient trial showing more favorable outcomes with Prestige LP than anterior cervical discectomy and fusion.

The US FDA has approved Medtronic PLC’s Prestige LP artificial disc for two-level cervical reconstruction, putting it in direct competition with LDR Holding Corp.’sMobi-C cervical disc.

According to FDA’s online PMA database, the agency approved a PMA supplement for a labeling change for Prestige LP to...

More from R&D

More from Business